For the quarter ending 2026-03-31, MXCT had -$5,508K decrease in cash & cash equivalents over the period. -$8,241K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Credit loss expense (recovery) | - | 6 | 19 | 10 |
| Loss on disposal of property and equipment | - | -155 | -19 | -113 |
| Net loss | -4,750 | -9,596 | -12,416 | -22,618 |
| Depreciation and amortization | 1,047 | 1,072 | 1,072 | 2,196 |
| Goodwill impairment | - | 3,554 | - | - |
| Lease right-of-use asset amortization | 221 | 215 | 209 | 378 |
| Net book value of consigned equipment sold | 14 | 13 | 15 | 55 |
| Stock-based compensation | 1,141 | 706 | 1,954 | 6,553 |
| Change in excess/obsolete inventory reserve | 197 | 151 | 360 | 165 |
| Amortization of discounts on investments | 437 | 427 | 584 | 1,635 |
| Accounts receivable | 743 | -4,797 | 2,572 | 1,077 |
| Inventory | 380 | 72 | 107 | -754 |
| Prepaid expense and other current assets | -69 | 1,275 | 29 | -773 |
| Other assets | 127 | -200 | -216 | 1,140 |
| Accounts payable, accrued expenses and other | -3,637 | -383 | 2,002 | -5,340 |
| Operating lease liability | -456 | -218 | -346 | -593 |
| Deferred revenue | -327 | -1,598 | 2,751 | -2,831 |
| Other liabilities | -1 | 11 | -21 | -26 |
| Net cash used in operating activities | -8,169 | -2,689 | -7,458 | -24,263 |
| Purchases of investments | 25,122 | 28,255 | 34,508 | 63,523 |
| Maturities of investments | 28,000 | 38,162 | 40,000 | 77,600 |
| Purchases of property and equipment | 72 | 231 | 300 | 1,237 |
| Acquisition of business, net of cash acquired of 541 | - | 0 | 0 | 1,773 |
| Acquisition of intangible assets | 150 | - | - | - |
| Net cash provided by investing activities | 2,656 | 9,676 | 5,192 | 11,067 |
| Proceeds from exercise of stock options | 5 | 15 | 14 | 403 |
| Proceeds from issuance of common stock under employee stock purchase plan | - | 90 | 0 | 134 |
| Net cash provided by financing activities | 5 | 105 | 14 | 537 |
| Net decrease in cash and cash equivalents | -5,508 | 7,092 | -2,252 | -12,659 |
| Cash and cash equivalents, beginning of period | 20,065 | 12,973 | 27,884 | - |
| Cash and cash equivalents, end of period | 14,557 | 20,065 | 12,973 | - |
MAXCYTE, INC. (MXCT)
MAXCYTE, INC. (MXCT)